(Q83364946)

English

Further evidence of antigenic drift and protective efficacy afforded by a recombinant HVT-H5 vaccine against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains

scientific article published on 01 February 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292007%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Further evidence of antigenic drift and protective efficacy afforded by a recombinant HVT-H5 vaccine against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292007%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Mohamed Ahmed Mohamed Ali Soliman

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292007%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

F Rauw

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292007%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

V Palya

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292007%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

S Van Borm

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292007%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

S Welby

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292007%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

T Tatar-Kis

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292007%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Y Gardin

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292007%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

K Moore Dorsey

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292007%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

M M Aly

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292007%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

M K Hassan

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292007%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

B Lambrecht

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292007%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

T van den Berg

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292007%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

1 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292007%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292007%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

29

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292007%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292007%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

2590-2600

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292007%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Epidemiological findings of outbreaks of disease caused by highly pathogenic H5N1 avian influenza virus in poultry in Egypt during 2006.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Principles for vaccine protection in chickens and domestic waterfowl against avian influenza: emphasis on Asian H5N1 high pathogenicity avian influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Influenza vaccines for avian species

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Avian influenza vaccination in Egypt: Limitations of the current strategy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Avian influenza vaccines: a practical review in relation to their application in the field with a focus on the Asian experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Inactivated North American and European H5N2 avian influenza virus vaccines protect chickens from Asian H5N1 high pathogenicity avian influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Sequence diversity of the haemagglutinin open reading frame of recent highly pathogenic avian influenza H5N1 isolates from Egypt.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Highly pathogenic avian influenza virus subtype H5N1 in Africa: a comprehensive phylogenetic analysis and molecular characterization of isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Antigenic and genetic diversity of highly pathogenic avian influenza A (H5N1) viruses isolated in Egypt

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Strategies and challenges for eliciting immunity against avian influenza virus in birds.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Genome analysis linking recent European and African influenza (H5N1) viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Continuing progress towards a unified nomenclature for the highly pathogenic H5N1 avian influenza viruses: divergence of clade 2.2 viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Avian herpesvirus as a live viral vector for the expression of heterologous antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek's diseases in specific-pathogen-free chickens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: onset of protection and effect of maternal antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Efficacy of single dose recombinant herpesvirus of turkey infectious bursal disease virus (IBDV) vaccination against a variant IBDV strain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Improved vaccination against Newcastle disease by an in ovo recombinant HVT-ND combined with an adjuvanted live vaccine at day-old

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Passive protection afforded by maternally-derived antibodies in chickens and the antibodies' interference with the protection elicited by avian influenza-inactivated vaccines in progeny

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Evaluation of the protection induced by avian influenza vaccines containing a 1994 Mexican H5N2 LPAI seed strain against a 2008 Egyptian H5N1 HPAI virus belonging to clade 2.2.1 by means of serological and in vivo tests

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Efficacy of an inactivated and a fowlpox-vectored vaccine in Muscovy ducks against an Asian H5N1 highly pathogenic avian influenza viral challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

A universal avian endogenous real-time reverse transcriptase-polymerase chain reaction control and its application to avian influenza diagnosis and quantification

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Prime-boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Humoral, cell-mediated and mucosal immunity induced by oculo-nasal vaccination of one-day-old SPF and conventional layer chicks with two different live Newcastle disease vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Comparison of the transmission characteristics of low and high pathogenicity avian influenza A virus (H5N2)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Design and analysis of small-scale transmission experiments with animals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Role of positive selection pressure on the evolution of H5N1 hemagglutinin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Puzzling inefficiency of H5N1 influenza vaccines in Egyptian poultry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Development of Real-Time RT-PCR for the Detection of Avian Influenza Virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

H5N1 outbreaks and enzootic influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Enhancement of natural killer cell activity by Marek's disease vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Recombinant Paramyxovirus Type 1-Avian Influenza-H7 Virus as a Vaccine for Protection of Chickens Against Influenza and Newcastle Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Use of antigenic cartography in vaccine seed strain selection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Cell-mediated protection in influenza infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Assessment of the cell-mediated immune response in chickens by detection of chicken interferon-gamma in response to mitogen and recall Newcastle disease viral antigen stimulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

The positive adjuvant effect of chitosan on antigen-specific cell-mediated immunity after chickens vaccination with live Newcastle disease vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Vaccines protect chickens against H5 highly pathogenic avian influenza in the face of genetic changes in field viruses over multiple years

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.048

7 January 2021

Identifiers

10.1016/J.VACCINE.2011.01.048

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292007%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292007%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83364946&oldid=1758473593"